Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
4 hedge funds and large institutions have $67K invested in Aoxing Pharmaceutical Company Inc. in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
319% more capital invested
Capital invested by funds: $16K → $67K (+$51K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$91K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.53K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$40 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
1
UBS
Zurich,
Switzerland
| $56K | +$91K | +287,244 | +42,936% |
|
|
2
Citadel Advisors
Miami,
Florida
| $8K | +$3.53K | +11,136 | +42% |
|
|
EWM
3
Evercore Wealth Management
New York
| $3K | – | – | – |
|
|
VKH
4
Virtu KCG Holdings
New York
| – | -$4K | -11,647 | Closed |
|
|
5
Wells Fargo
San Francisco,
California
| – | +$40 | +125 | New |
|
AXN Hedge Fund Activity: Q3 2014 in Review
4 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q3 2014, worth a combined $67K — up 319% from $16K a quarter earlier.
Fund positioning in AXN was balanced in Q3 2014: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS, adding an estimated $91K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $4K sold.
- 4 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $67K of Aoxing Pharmaceutical Company Inc. stock for Q3 2014, up 319% quarter-over-quarter.
- 1 fund opened new Aoxing Pharmaceutical Company Inc. positions in Q3 2014 and 1 closed out, a net change of 0 holders.
- The largest Aoxing Pharmaceutical Company Inc. buyer in Q3 2014 was UBS, an estimated $91K added.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q3 2014 was Virtu KCG Holdings, an estimated $4K sold.
Based on aggregated 13F filings for Q3 2014.